SMARCB1 and meningioma: Biallelic inactivation of SMARCB1 has been observed in both schwannomas and meningiomas of patients with schwannomatosis (Boyd et al. 2008; Sestini et al. 2008; Hadfield et al. 2008, 2010a; Smith et al. 2012b).